non-alcoholic fatty liver disease. non-alcoholic, fatty liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: grade 1,2 & 3 fatty liver, new fatty liver diagnosed patients, and fatty liver confirmed by physician. Alt>30 in males and ALt>19 in females. age: 18-65 BMI>25 controlled Diabetes and lipid profile.
Exclusion criteria
Exclusion criteria: presence of another type of liver disease, cirrhosis, hepatitis B and C, cardiovascular and kidney disease, autoimmune, hypothyroidism, wilson, cystic fibrosis, Deficiency of alpha-1-antitrypsin 1, inflammatory bowel disease and hemochromatosis. using alcohol taking nutritional and probiotic supplements within the previous 6 weeks. having weight loss more than 3 Kg within 3 month ago participating in other trials in the last 6 month being pregnant or breast feeding do not want to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alanine aminotransferase. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: ALT kit.;Aspartate transaminase. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: AST kit.;Weight. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: seca scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: Mercury barometric device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences